Retatrutide

The total pooled evaluation showed a statistically considerable percent reduction in body weight of the retatrutide group when compared to the placebo team after 36 weeks of therapy, with a general MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide side effects liver</a> revealed that users could lose up to a quarter of their body weight in under a year, making it nearly twice as reliable as Ozempic.